Gene info: ID 60

Gene: ACTB

GENE ID: 60

Synonyms: BRWS1|PS1TP5BP1

Description: actin beta

Gene type: protein-coding

Location: 7p22.1

dbXrefs: Ensembl:ENSG00000075624 MIM:102630 Vega:OTTHUMG00000023268 UniprotKB:P60709

RefSeq: NG_007992.1

Retrived from: PubMed

SNPs: 0 ANCO-SNPs

Phenotype: ND|AD

# Publications: 3

Sherlock p-value : NA (AD) NA (ND) (Frontal_Cortex)

Pascal p-value : 1.435e-1 (AD) 7.791e-1 (ND)

DNA Methylation

Probe	Locus(GRCh37)	Gene	Region	p-val	Trait	PubMed ID
cg01741041	chr7:5567862	ACTB		2.150e-10	Maternal smoking in pregnancy	27040690
cg14145074	chr7:5567891	ACTB		1.870e-8	Maternal smoking in pregnancy	27040690
cg01741041	chr7:5567862	ACTB		1.970e-8	Maternal smoking in pregnancy	27040690
cg05971148	chr7:5568411	ACTB		6.500e-12	Smoking	27651444
cg14145074	chr7:5567891	ACTB		1.020e-8	Alcohol consumption der day	27843151

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
ACTG1	0.972
CSNK2B	0.962
RAB7A	0.957
HNRNPD	0.954
GAPDH	0.953
PCBP2	0.952
PSMB4	0.952
PHB2	0.951
MRFAP1	0.945
CAPZB	0.944

Top 10 negatively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
OR4F5	-0.908
OR4F29	-0.894
MTRNR2L6	-0.137
HMHB1	-0.132
MTRNR2L9	-0.123
OR6C74	-0.119
LCE3B	-0.098
PRDM14	-0.097
CCR8	-0.095
FANCD2OS	-0.095

There is no DrugBank record for this gene !

ID	Drug Name	Action	PubMed
C081014	1,2-bis(2,4,6-tribromophenoxy)ethane	"1,2-bis(2,4,6-tribromophenoxy)ethane results in increased expression of ACTB mRNA"	28249227
C016614	1-nitronaphthalene	1-nitronaphthalene metabolite binds to ACTB protein	16453347
C016403	2,4-dinitrotoluene	"2,4-dinitrotoluene affects the expression of ACTB mRNA"	21346803
C024709	2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone	"2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to ACTB protein"	16533022
C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of ACTB mRNA"	15215175
C030370	2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone	"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone affects the expression of ACTB mRNA"	20206263
C054649	3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol	"3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in decreased expression of ACTB mRNA"	12734338
C472791	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of ACTB mRNA	12958071
C027576	4-hydroxy-2-nonenal	ACTB protein binds to 4-hydroxy-2-nonenal	20043646
C012606	4-vinyl-1-cyclohexene dioxide	4-vinyl-1-cyclohexene dioxide affects the expression of ACTB mRNA	20829426
C011421	5-chloro-2-methyl-4-isothiazolin-3-one	5-chloro-2-methyl-4-isothiazolin-3-one results in increased metabolism of ACTB protein	29267982
C048324	abamectin	abamectin results in decreased expression of ACTB protein	19879343
D000082	Acetaminophen	Acetaminophen affects the expression of ACTB mRNA	17562736
D000082	Acetaminophen	Acetaminophen affects the expression of ACTB mRNA	20732408
D000082	Acetaminophen	Acetaminophen results in increased expression of ACTB mRNA	22563491
D000082	Acetaminophen	Acetaminophen results in increased expression of ACTB protein	16687475
D019342	Acetic Acid	Acetic Acid affects the expression of ACTB protein	21296659
D000171	Acrolein	Acrolein results in increased metabolism of ACTB protein	17570602
D016604	Aflatoxin B1	Aflatoxin B1 results in increased expression of ACTB mRNA	27153756
D016604	Aflatoxin B1	Aflatoxin B1 results in decreased expression of ACTB mRNA	19770486
D000496	Alloxan	Alloxan results in decreased expression of ACTB mRNA	12137914
D000517	alpha-Chlorohydrin	alpha-Chlorohydrin affects the expression of ACTB protein	26072098
D000517	alpha-Chlorohydrin	alpha-Chlorohydrin analog affects the expression of ACTB protein	26072098
D000517	alpha-Chlorohydrin	alpha-Chlorohydrin analog results in decreased expression of ACTB protein	26597043
D000517	alpha-Chlorohydrin	alpha-Chlorohydrin results in decreased expression of ACTB protein	26597043
D000499	Allylamine	Allylamine results in increased expression of ACTB mRNA	15910882
D000643	Ammonium Chloride	Ammonium Chloride results in decreased expression of ACTB mRNA	16483693
D000643	Ammonium Chloride	Ammonium Chloride results in decreased expression of ACTB protein	16483693
D003913	Dextroamphetamine	Dextroamphetamine results in decreased expression of ACTB mRNA	12558987
D001151	Arsenic	Arsenic results in decreased expression of ACTB mRNA	18315880
C006632	arsenic trioxide	arsenic trioxide results in decreased expression of ACTB mRNA	20458559
C006632	arsenic trioxide	arsenic trioxide results in decreased expression of ACTB protein	20452446
C006632	arsenic trioxide	arsenic trioxide results in increased expression of ACTB mRNA	11940349\|2045244
D001241	Aspirin	Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of ACTB protein]	17303692
C028559	bathocuproine sulfonate	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA]	15477007
C004456	beauvericin	beauvericin results in decreased expression of ACTB mRNA	29203277
D001554	Benzene	Benzene affects the expression of ACTB mRNA	15878777
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of ACTB mRNA	20064835\|2010694
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of ACTB protein	18495319
D001564	Benzo(a)pyrene	[Soot co-treated with Benzo(a)pyrene] results in increased expression of ACTB protein modified form	24464499
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of ACTB mRNA	15034205
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of ACTB mRNA	22228805
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of ACTB protein	20719421
D001564	Benzo(a)pyrene	[Cadmium Chloride co-treated with Benzo(a)pyrene] results in increased expression of ACTB protein	20719421
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ACTB mRNA	15857753
C044887	beta-methylcholine	beta-methylcholine affects the expression of ACTB mRNA	21179406
C006780	bisphenol A	bisphenol A results in decreased expression of ACTB mRNA	25047013
C006780	bisphenol A	bisphenol A results in decreased expression of ACTB protein	25772901
C006780	bisphenol A	bisphenol A results in increased methylation of ACTB promoter	27312807
C006780	bisphenol A	bisphenol A results in increased expression of ACTB mRNA	25181051
C006780	bisphenol A	bisphenol A results in increased methylation of ACTB gene	28505145
C013418	bromfenacoum	bromfenacoum results in decreased expression of ACTB protein	28903499
C032036	bromobenzene	bromobenzene results in increased expression of ACTB mRNA	16036859
C099813	bromochloroacetic acid	bromochloroacetic acid results in increased expression of ACTB protein	21296659
C022777	bufalin	bufalin results in increased expression of ACTB protein	23091618
D002065	Buspirone	Buspirone results in decreased expression of ACTB mRNA	24136188
D019328	Buthionine Sulfoximine	Buthionine Sulfoximine results in decreased expression of ACTB mRNA	15878706
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide results in decreased expression of ACTB mRNA	12419474
C018475	butyraldehyde	butyraldehyde results in increased expression of ACTB mRNA	26079696
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of ACTB protein	16372273
D019256	Cadmium Chloride	Cadmium Chloride affects the expression of ACTB protein	24874008
D019256	Cadmium Chloride	Cadmium Chloride affects the expression of ACTB mRNA	23828170
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of ACTB protein	20452446
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of ACTB mRNA	20452446\|2588268
D019256	Cadmium Chloride	Cadmium Chloride affects the expression of ACTB mRNA	18804290
D019256	Cadmium Chloride	[Cadmium Chloride co-treated with Benzo(a)pyrene] results in increased expression of ACTB protein	20719421
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of ACTB protein	20719421
C034939	cadmium sulfide	[cadmium telluride co-treated with cadmium sulfide] results in increased expression of ACTB mRNA	20596552
C028337	cadmium telluride	[cadmium telluride co-treated with cadmium sulfide] results in increased expression of ACTB mRNA	20596552
D002118	Calcium	[Calcium co-treated with Calcitriol] affects the expression of ACTB mRNA	15913539
D002246	Carbon Disulfide	Carbon Disulfide results in increased expression of ACTB mRNA	17498345
D002246	Carbon Disulfide	Carbon Disulfide results in increased expression of ACTB protein	16474999\|1749834
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of ACTB mRNA	18395095
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of ACTB protein	18395095
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of ACTB mRNA	22563491
D002251	Carbon Tetrachloride	[Olive Oil analog co-treated with Carbon Tetrachloride] affects the expression of ACTB protein	25303780
D002273	Carcinogens	Carcinogens results in increased expression of ACTB mRNA	16316942
D002392	Catechin	"Catechin inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]"	19743802
D020111	Chlorodiphenyl (54% Chlorine)	Chlorodiphenyl (54% Chlorine) results in decreased expression of ACTB mRNA	23650126
D020111	Chlorodiphenyl (54% Chlorine)	Chlorodiphenyl (54% Chlorine) results in decreased expression of ACTB mRNA	18804290
D020111	Chlorodiphenyl (54% Chlorine)	Chlorodiphenyl (54% Chlorine) results in increased expression of ACTB mRNA	18178546
C100187	chloropicrin	chloropicrin results in decreased expression of ACTB mRNA	26352163
C012843	cinnamic aldehyde	cinnamic aldehyde results in increased metabolism of ACTB protein	29267982
D002994	Clofibrate	Clofibrate results in decreased expression of ACTB mRNA	17585979
D002994	Clofibrate	Clofibrate results in decreased expression of ACTB mRNA	22300585
D002994	Clofibrate	Clofibrate results in increased expression of ACTB protein	16470657
D003033	Coal Tar	Coal Tar results in increased expression of ACTB protein	18495319
D019327	Copper Sulfate	Copper Sulfate results in decreased expression of ACTB protein	20452446
D019327	Copper Sulfate	Copper Sulfate results in increased expression of ACTB mRNA	19549813\|2045244
C029892	cupric chloride	cupric chloride results in decreased expression of ACTB protein	22030410
C057862	cyanoginosin LR	cyanoginosin LR results in decreased expression of ACTB mRNA	17383702
C057862	cyanoginosin LR	cyanoginosin LR results in decreased expression of ACTB mRNA	23342045
D003520	Cyclophosphamide	Cyclophosphamide results in decreased expression of ACTB mRNA	12167460
D003520	Cyclophosphamide	Cyclophosphamide affects the expression of ACTB mRNA	10859244
D016572	Cyclosporine	Cyclosporine results in decreased expression of ACTB mRNA	21632981
D016572	Cyclosporine	Cyclosporine results in increased secretion of ACTB protein	21354196
D003634	DDT	DDT results in decreased expression of ACTB protein	26186133
C007262	deoxynivalenol	deoxynivalenol results in increased expression of ACTB mRNA	26417708
D003907	Dexamethasone	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA	16054899
D003907	Dexamethasone	Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA]	16054899
C041517	dibenzo(a,l)pyrene	"dibenzo(a,l)pyrene results in increased expression of ACTB protein"	18495319
D003993	Dibutyl Phthalate	Dibutyl Phthalate results in increased expression of ACTB mRNA	21266533
D003993	Dibutyl Phthalate	Dibutyl Phthalate results in increased expression of ACTB mRNA	21266533
D002945	Cisplatin	[Cisplatin co-treated with jinfukang] results in decreased expression of ACTB mRNA	27392435
D002945	Cisplatin	Cisplatin results in decreased expression of ACTB mRNA	27594783
C000944	dicrotophos	dicrotophos results in increased expression of ACTB mRNA	28302478
D004026	Dieldrin	Dieldrin results in decreased expression of ACTB protein	20584760
D004026	Dieldrin	Dieldrin results in increased expression of ACTB protein	20584760
D004041	Dietary Fats	Dietary Fats results in increased expression of ACTB mRNA	22609946
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of ACTB protein	28934723
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in decreased expression of ACTB protein	16400681
D004054	Diethylstilbestrol	Diethylstilbestrol results in decreased expression of ACTB mRNA	15171707
D002117	Calcitriol	[Calcium co-treated with Calcitriol] affects the expression of ACTB mRNA	15913539
D015102	3,4-Dihydroxyphenylacetic Acid	"3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein"	19743802
D015102	3,4-Dihydroxyphenylacetic Acid	"Catechin inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]"	19743802
D015102	3,4-Dihydroxyphenylacetic Acid	"epicatechin gallate inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]"	19743802
D015102	3,4-Dihydroxyphenylacetic Acid	"Quercetin inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]"	19743802
D015127	9,10-Dimethyl-1,2-benzanthracene	"9,10-Dimethyl-1,2-benzanthracene affects the expression of ACTB mRNA"	21785161
D004137	Dinitrochlorobenzene	Dinitrochlorobenzene results in increased metabolism of ACTB protein	29267982
D004298	Dopamine	Dopamine affects the expression of ACTB protein	24675778
C084101	doramectin	doramectin results in decreased expression of ACTB protein	19879343
D004317	Doxorubicin	Doxorubicin affects the expression of ACTB protein	29385562
D004317	Doxorubicin	Doxorubicin results in increased oxidation of ACTB protein	28818578
D004785	Environmental Pollutants	Environmental Pollutants results in increased expression of ACTB mRNA	20064776
C062669	epicatechin gallate	"epicatechin gallate inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]"	19743802
D000431	Ethanol	Ethanol results in decreased expression of ACTB protein	23702218
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in decreased expression of ACTB mRNA	17215170
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in decreased expression of ACTB mRNA	17288598
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in increased expression of ACTB mRNA	23550701
C504383	fenbuconazole	fenbuconazole results in increased expression of ACTB mRNA	15942997
D005411	Flame Retardants	Flame Retardants results in decreased expression of ACTB protein	18550172
D005411	Flame Retardants	Flame Retardants results in increased expression of ACTB protein	18550172
C024352	fludarabine	[LAQ824 co-treated with fludarabine] results in increased expression of ACTB mRNA	18852132
D005472	Fluorouracil	Fluorouracil results in decreased expression of ACTB protein	21296659
D005485	Flutamide	Flutamide results in increased expression of ACTB mRNA	24136188
C039281	furan	furan results in increased expression of ACTB mRNA	15120968
D005688	Galactosamine	Galactosamine results in increased expression of ACTB mRNA	22563491
D019833	Genistein	Genistein results in decreased expression of ACTB mRNA	22228119
D005839	Gentamicins	Gentamicins results in increased expression of ACTB mRNA	22061828
D005947	Glucose	Glucose deficiency results in decreased expression of ACTB protein	22314686
D005947	Glucose	[INS protein co-treated with Glucose] results in increased expression of ACTB mRNA	22634610
D006820	Hyaluronic Acid	Hyaluronic Acid analog affects the expression of ACTB protein	23178681
D006820	Hyaluronic Acid	Hyaluronic Acid analog affects the reaction [Hydrogen Peroxide results in decreased expression of ACTB protein]	23178681
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in decreased expression of ACTB mRNA	12419474
D006861	Hydrogen Peroxide	Hyaluronic Acid analog affects the reaction [Hydrogen Peroxide results in decreased expression of ACTB protein]	23178681
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in decreased expression of ACTB protein	23178681
D002112	Calcifediol	Calcifediol deficiency results in decreased expression of ACTB mRNA	17293106
C474021	indirubin-3'-monoxime	indirubin-3'-monoxime affects the expression of ACTB protein	18958680
D015759	Ionomycin	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA]	15477007
D015759	Ionomycin	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA	15477007
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA	16054899
D015056	1-Methyl-3-isobutylxanthine	Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA]	16054899
D007545	Isoproterenol	Isoproterenol results in decreased expression of ACTB mRNA	20003209
C544151	jinfukang	[Cisplatin co-treated with jinfukang] results in decreased expression of ACTB mRNA	27392435
C410337	K 7174	K 7174 results in decreased expression of ACTB mRNA	24086573
D007657	Ketone Bodies	Ketone Bodies results in increased expression of ACTB mRNA	16807920
C477361	LAQ824	[LAQ824 co-treated with fludarabine] results in increased expression of ACTB mRNA	18852132
C037067	latrunculin A	ACTB protein mutant form results in decreased susceptibility to latrunculin A	16685646
D007854	Lead	Lead affects the expression of ACTB mRNA	28903495
C008261	lead acetate	lead acetate affects the expression of ACTB protein	20797405
C029891	lead chloride	lead chloride results in decreased expression of ACTB protein	24419708
C045463	leflunomide	leflunomide results in increased expression of ACTB mRNA	28988120
D001556	Lindane	Lindane results in decreased expression of ACTB mRNA	18804290
D001556	Lindane	Lindane affects the expression of ACTB mRNA	22001173
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of ACTB mRNA	11779202
D008094	Lithium	Lithium results in increased expression of ACTB protein	18296634
D008148	Lovastatin	Lovastatin results in decreased expression of ACTB mRNA	20493250
D008148	Lovastatin	Lovastatin results in increased expression of ACTB mRNA	20493250
D058185	Magnetite Nanoparticles	Magnetite Nanoparticles results in decreased expression of ACTB mRNA	24525745
C025340	manganese chloride	manganese chloride results in decreased expression of ACTB protein	20452446
C025340	manganese chloride	manganese chloride results in increased expression of ACTB mRNA	20452446
D008627	Mercuric Chloride	Mercuric Chloride results in decreased expression of ACTB protein	20452446
D008627	Mercuric Chloride	Mercuric Chloride results in increased expression of ACTB mRNA	20452446
D008628	Mercury	Mercury results in increased expression of ACTB mRNA	22688007
D008694	Methamphetamine	Methamphetamine results in decreased expression of ACTB protein	19826936
C004925	methylmercuric chloride	methylmercuric chloride results in increased expression of ACTB mRNA	26272509
C004925	methylmercuric chloride	methylmercuric chloride results in decreased expression of ACTB protein	22265609
D008741	Methyl Methanesulfonate	Methyl Methanesulfonate results in decreased expression of ACTB mRNA	23649840
D018817	N-Methyl-3,4-methylenedioxyamphetamine	"N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACTB mRNA"	20188158
D008770	Methylnitrosourea	Methylnitrosourea results in increased mutagenesis of ACTB gene	10767621
D015655	1-Methyl-4-phenylpyridinium	1-Methyl-4-phenylpyridinium results in decreased expression of ACTB protein	24675778
D015741	Metribolone	Metribolone promotes the reaction [NDRG1 protein binds to ACTB protein]	17220478
D015741	Metribolone	Metribolone results in increased expression of ACTB protein	17152098
D015735	Mifepristone	Mifepristone results in decreased expression of ACTB mRNA	17584828
C028577	monobutyl phthalate	monobutyl phthalate results in increased expression of ACTB protein	20553848
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in decreased expression of ACTB mRNA"	28673683
D037742	Nanotubes, Carbon	"Nanotubes, Carbon affects the expression of ACTB protein"	21135415
C000621033	napabucasin	napabucasin results in decreased expression of ACTB mRNA	25605917
C031721	naphthalene	naphthalene metabolite binds to ACTB protein	16453347
C031721	naphthalene	naphthalene metabolite binds to ACTB protein	15892573
C031721	naphthalene	naphthalene results in increased expression of ACTB protein	19438287
D009532	Nickel	Nickel results in increased expression of ACTB mRNA	25583101
C119536	nickel acetate	nickel acetate affects the expression of ACTB mRNA	23828170
C022838	nickel chloride	nickel chloride results in decreased expression of ACTB protein	20452446
C022838	nickel chloride	nickel chloride results in increased expression of ACTB mRNA	20452446
C028007	nickel monoxide	nickel monoxide results in decreased expression of ACTB mRNA	19167457
D009538	Nicotine	Nicotine results in increased expression of ACTB mRNA	17997037
D009569	Nitric Oxide	Nitric Oxide deficiency results in decreased expression of ACTB mRNA	15878706
D005996	Nitroglycerin	Nitroglycerin results in decreased expression of ACTB mRNA	12102619
C014707	nitrosobenzylmethylamine	nitrosobenzylmethylamine results in increased expression of ACTB mRNA	17616710
C002741	N-nitrosomorpholine	N-nitrosomorpholine affects the expression of ACTB protein	19716841
C002741	N-nitrosomorpholine	N-nitrosomorpholine results in decreased expression of ACTB protein	19716841
C025256	nonylphenol	nonylphenol results in increased expression of ACTB protein	19260726
D000069463	Olive Oil	[Olive Oil analog co-treated with Carbon Tetrachloride] affects the expression of ACTB protein	25303780
C507134	ON 01910	ON 01910 results in increased expression of ACTB mRNA	22351695
D010100	Oxygen	Oxygen deficiency affects the expression of ACTB protein	19579223
D010100	Oxygen	Oxygen deficiency promotes the reaction [KDM1A protein binds to ACTB promoter]	25043185
D010126	Ozone	Ozone results in decreased expression of ACTB mRNA	16330353
D010261	Paraoxon	Paraoxon results in increased expression of ACTB protein	20931991
D010269	Paraquat	Paraquat results in increased expression of ACTB mRNA	20883675
C086401	pentabromodiphenyl ether	pentabromodiphenyl ether results in decreased expression of ACTB protein	18550172
C086401	pentabromodiphenyl ether	pentabromodiphenyl ether results in increased expression of ACTB protein	18550172
C033094	perfluorobutyric acid	perfluorobutyric acid results in decreased expression of ACTB mRNA	23567314
C101816	perfluoro-n-nonanoic acid	perfluoro-n-nonanoic acid results in decreased expression of ACTB mRNA	23567314
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of ACTB mRNA]	19167519
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in decreased expression of ACTB mRNA	19167519
C023036	perfluorooctanoic acid	perfluorooctanoic acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of ACTB mRNA]	19167519
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in decreased expression of ACTB mRNA	19162173
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in decreased expression of ACTB mRNA	18804290
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of ACTB protein	19616056
C011272	perfosfamide	perfosfamide results in decreased expression of ACTB mRNA	19429390
C058305	phenethyl isothiocyanate	ACTB protein binds to phenethyl isothiocyanate	21838287
D010695	Phlorhizin	Phlorhizin results in increased expression of ACTB mRNA	22538082
D010862	Pilocarpine	Pilocarpine promotes the reaction [EIF2S1 protein modified form results in decreased expression of ACTB protein]	16492139
D011374	Progesterone	Progesterone affects the expression of ACTB mRNA	17251523
C045950	propiconazole	propiconazole results in decreased expression of ACTB mRNA	19363144
D011692	Puromycin Aminonucleoside	Puromycin Aminonucleoside results in decreased expression of ACTB protein	19264907
C020972	pyrrolidine dithiocarbamic acid	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA]	15477007
D011794	Quercetin	Quercetin analog binds to ACTB protein mutant form	21798748
D011794	Quercetin	Quercetin results in decreased expression of ACTB mRNA	21632981
D011794	Quercetin	"Quercetin inhibits the reaction [3,4-Dihydroxyphenylacetic Acid analog binds to ACTB protein]"	19743802
C502851	quinocetone	quinocetone results in decreased expression of ACTB protein	27046791
C502851	quinocetone	quinocetone results in increased expression of ACTB protein	27046791
C059514	resveratrol	resveratrol affects the expression of ACTB mRNA	15748624
D012176	Retinoids	Retinoids results in increased expression of ACTB protein	28886987
C089730	rosiglitazone	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA	16054899
C089730	rosiglitazone	Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA]	16054899
D012643	Selenium	Selenium results in increased expression of ACTB mRNA	19244175
D017632	Asbestos, Serpentine	"Asbestos, Serpentine results in increased expression of ACTB mRNA"	23706555
D017632	Asbestos, Serpentine	"Asbestos, Serpentine results in increased expression of and results in increased phosphorylation of ACTB protein"	23706555
D012822	Silicon Dioxide	Silicon Dioxide analog affects the secretion of ACTB protein	25895662
D012834	Silver	Silver results in decreased expression of ACTB mRNA	19429238
D012834	Silver	Silver analog results in decreased expression of ACTB mRNA	22727896
D012835	Silver Nitrate	Silver Nitrate results in decreased expression of ACTB mRNA	22727896
D019821	Simvastatin	Simvastatin results in increased expression of ACTB mRNA	25055962
D020123	Sirolimus	[Sirolimus binds to FKBP1A protein] which results in increased expression of ACTB mRNA	7503980
D020123	Sirolimus	Sirolimus results in increased expression of ACTB mRNA	7503980
C009277	sodium arsenate	sodium arsenate results in increased expression of ACTB mRNA	21795629
C017947	sodium arsenite	sodium arsenite affects the expression of ACTB mRNA	19590694
C017947	sodium arsenite	sodium arsenite results in increased expression of ACTB mRNA	19072884
D012969	Sodium Fluoride	Sodium Fluoride results in decreased expression of ACTB protein	27548804
D012969	Sodium Fluoride	Sodium Fluoride results in increased expression of ACTB mRNA	27862939
D018038	Sodium Selenite	Sodium Selenite results in increased expression of ACTB mRNA	18175754
D053260	Soot	[Soot co-treated with Benzo(a)pyrene] results in increased expression of ACTB protein modified form	24464499
D053260	Soot	Soot results in decreased expression of ACTB protein	24464499
D053260	Soot	Soot results in decreased expression of ACTB protein modified form	24464499
C041711	St. Thomas' Hospital cardioplegic solution	St. Thomas' Hospital cardioplegic solution results in increased expression of ACTB mRNA	16214533
C016766	sulforafan	ACTB protein binds to sulforafan	21838287
D013605	T-2 Toxin	T-2 Toxin affects the expression of ACTB protein	26141394
C534735	tetraarsenic tetrasulfide	tetraarsenic tetrasulfide affects the expression of ACTB protein	24430359
D013749	Tetrachlorodibenzodioxin	perfluorooctane sulfonic acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of ACTB mRNA]	19167519
D013749	Tetrachlorodibenzodioxin	perfluorooctanoic acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of ACTB mRNA]	19167519
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of ACTB mRNA	21570461
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin promotes the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTB mRNA]	16054899
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of ACTB mRNA	15591033\|1869160
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of ACTB mRNA	15034205
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of ACTB mRNA	15703262
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of ACTB mRNA	16267337
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of ACTB mRNA	16054898\|1646670
D013750	Tetrachloroethylene	Tetrachloroethylene results in decreased expression of ACTB mRNA	28973375
D013755	Tetradecanoylphorbol Acetate	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA]	15477007
D013755	Tetradecanoylphorbol Acetate	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA	15477007
D015647	2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine	"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine affects the expression of ACTB protein"	25852303
D013853	Thioacetamide	Thioacetamide results in decreased expression of ACTB mRNA	18395095
D013853	Thioacetamide	Thioacetamide results in decreased expression of ACTB protein	18395095
D013853	Thioacetamide	Thioacetamide results in increased expression of ACTB mRNA	22563491
C096900	thrombin receptor-activating peptide SFLLRNPNDKY	Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of ACTB protein]	17303692
C096900	thrombin receptor-activating peptide SFLLRNPNDKY	thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of ACTB protein	17303692
C009495	titanium dioxide	titanium dioxide results in increased expression of ACTB mRNA	23557971
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in increased metabolism of ACTB protein	23396223
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution affects the expression of ACTB mRNA	20133372
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in decreased expression of ACTB mRNA	28111298
D014212	Tretinoin	Tretinoin affects the expression of ACTB protein	15789344
C032910	triadimefon	triadimefon results in decreased expression of ACTB mRNA	19363144
D014241	Trichloroethylene	Trichloroethylene results in increased expression of ACTB mRNA	19254012
D014302	Trinitrobenzenesulfonic Acid	Trinitrobenzenesulfonic Acid results in increased expression of ACTB mRNA	17982090
D014302	Trinitrobenzenesulfonic Acid	Trinitrobenzenesulfonic Acid results in decreased expression of ACTB mRNA	12163651
C001899	triptolide	triptolide results in decreased expression of ACTB mRNA	27554044
C001899	triptolide	triptolide results in decreased expression of ACTB protein	27554044
C013320	tris(2-butoxyethyl) phosphate	tris(2-butoxyethyl) phosphate affects the expression of ACTB mRNA	29024780
C080163	trovafloxacin	trovafloxacin results in decreased expression of ACTB mRNA	24136188
D014501	Uranium	Uranium affects the expression of ACTB mRNA	15672453
D014501	Uranium	Uranium affects the expression of ACTB protein	15672453
C005460	uranyl acetate	uranyl acetate affects the expression of ACTB mRNA	15672453
C005460	uranyl acetate	uranyl acetate affects the expression of ACTB protein	15672453
D014635	Valproic Acid	Valproic Acid results in increased expression of ACTB mRNA	23179753\|2718838
D014635	Valproic Acid	Valproic Acid results in increased methylation of ACTB gene	29154799
D014635	Valproic Acid	Valproic Acid results in increased expression of ACTB mRNA	23665938
D014640	Vancomycin	Vancomycin results in increased expression of ACTB mRNA	18930951
D001335	Vehicle Emissions	Vehicle Emissions results in decreased expression of ACTB protein	18495319
D001335	Vehicle Emissions	Vehicle Emissions results in increased expression of ACTB protein	18495319
C025643	vinclozolin	vinclozolin affects the expression of ACTB mRNA	19015723
C025643	vinclozolin	vinclozolin results in increased expression of ACTB protein	20616205
D014800	Vitallium	Vitallium analog results in decreased expression of ACTB mRNA	23825117
D014801	Vitamin A	Vitamin A deficiency results in decreased expression of ACTB mRNA	12163651
D014810	Vitamin E	Vitamin E results in increased expression of ACTB mRNA	19244175
D014859	Warfarin	Warfarin results in decreased expression of ACTB mRNA	20493250
D014859	Warfarin	Warfarin results in increased expression of ACTB mRNA	20493250
D019287	Zinc Sulfate	Zinc Sulfate affects the expression of ACTB protein	25162517
C028541	zirconium oxide	zirconium oxide results in increased expression of ACTB mRNA	17197017

GO/Pathway

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000978	RNA polymerase II proximal promoter sequence-specific DNA binding	contributes_to	HDA	16217013
GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	contributes_to	HDA	16217013
GO:0005200	structural constituent of cytoskeleton	-	TAS	6202424
GO:0005515	protein binding	-	IPI	11682052 11687588 14592989 15047060 15161933 15328537 15527767 16189514 16375898 17192268 17342765 17404223 17502619 17599063 17823310 18331289 18562541 19000816 19008859 19328794 19338310 20473970 20618440 21044950 21516116 21555369 21577206 23100250 25416956 25910212 27107014
GO:0005524	ATP binding	-	IEA	-
GO:0019894	kinesin binding	-	IPI	18680169
GO:0019901	protein kinase binding	-	IPI	24327345
GO:0030957	Tat protein binding	-	IPI	16687403
GO:0031492	nucleosomal DNA binding	contributes_to	HDA	16217013
GO:0042802	identical protein binding	-	IPI	16189514 17404223 18234857 19000816 20383143 21516116 25416956 25910212
GO:0050998	nitric-oxide synthase binding	-	IPI	17502619
GO:0098973	structural constituent of postsynaptic actin cytoskeleton	-	IDA	18341992

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	-	ISS	-
GO:0001895	retina homeostasis	-	HEP	23580065
GO:0016579	protein deubiquitination	-	TAS	-
GO:0021762	substantia nigra development	-	HEP	22926577
GO:0022898	regulation of transmembrane transporter activity	-	IGI	18331289
GO:0022898	regulation of transmembrane transporter activity	-	ISS	18331289
GO:0032091	negative regulation of protein binding	-	ISS	-
GO:0034329	cell junction assembly	-	TAS	-
GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	-	TAS	-
GO:0043044	ATP-dependent chromatin remodeling	-	HDA	16217013
GO:0045815	positive regulation of gene expression, epigenetic	-	TAS	-
GO:0048013	ephrin receptor signaling pathway	-	TAS	-
GO:0048870	cell motility	-	IMP	6202424
GO:0051621	regulation of norepinephrine uptake	-	IGI	18331289
GO:0051621	regulation of norepinephrine uptake	-	ISS	18331289
GO:0051623	positive regulation of norepinephrine uptake	-	TAS	18331289
GO:0061024	membrane organization	-	TAS	-
GO:0070527	platelet aggregation	-	HMP	23382103
GO:0072749	cellular response to cytochalasin B	-	IMP	6202424
GO:0098974	postsynaptic actin cytoskeleton organization	-	IDA	18341992
GO:1903076	regulation of protein localization to plasma membrane	-	IMP	18331289

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000790	nuclear chromatin	-	HDA	16217013
GO:0005615	extracellular space	-	HDA	16502470 22664934 23580065
GO:0005634	nucleus	-	IDA	11687588
GO:0005654	nucleoplasm	-	TAS	-
GO:0005737	cytoplasm	-	IDA	24327345
GO:0005737	cytoplasm	-	TAS	16130169
GO:0005829	cytosol	-	TAS	-
GO:0005856	cytoskeleton	-	IDA	24327345
GO:0005856	cytoskeleton	-	ISS	-
GO:0005856	cytoskeleton	-	TAS	16130169
GO:0005886	plasma membrane	-	ISS	-
GO:0005886	plasma membrane	-	TAS	-
GO:0005925	focal adhesion	-	HDA	21423176
GO:0015629	actin cytoskeleton	-	IDA	11687588
GO:0016020	membrane	-	HDA	19946888
GO:0031982	vesicle	-	HDA	19190083
GO:0032991	protein-containing complex	-	HDA	16217013
GO:0032991	protein-containing complex	-	IDA	11687588
GO:0035267	NuA4 histone acetyltransferase complex	-	IDA	10966108
GO:0036464	cytoplasmic ribonucleoprotein granule	-	IDA	15121898
GO:0070062	extracellular exosome	-	HDA	11487543 19199708 20458337 21362503 23533145
GO:0072562	blood microparticle	-	HDA	22516433
GO:0097433	dense body	-	ISS	-
GO:0098793	presynapse	-	TAS	18331289
GO:1990904	ribonucleoprotein complex	-	IDA	17289661

KEGG ID	KEGG Term
hsa04145	Phagosome
hsa04510	Focal adhesion
hsa04520	Adherens junction
hsa04530	Tight junction
hsa04670	Leukocyte transendothelial migration
hsa04810	Regulation of actin cytoskeleton
hsa04971	Gastric acid secretion
hsa05100	Bacterial invasion of epithelial cells
hsa05110	Vibrio cholerae infection
hsa05130	Pathogenic Escherichia coli infection
hsa05131	Shigellosis
hsa05410	Hypertrophic cardiomyopathy (HCM)
hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)
hsa05414	Dilated cardiomyopathy
hsa05416	Viral myocarditis

Reactome ID	Reactome Term	Evidence
R-HSA-109582	Hemostasis	IEA
R-HSA-1266738	Developmental Biology	TAS
R-HSA-1266738	Developmental Biology	IEA
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	IEA
R-HSA-1500931	Cell-Cell communication	TAS
R-HSA-1500931	Cell-Cell communication	IEA
R-HSA-157858	Gap junction trafficking and regulation	TAS
R-HSA-162582	Signal Transduction	TAS
R-HSA-162582	Signal Transduction	IEA
R-HSA-1643685	Disease	TAS
R-HSA-168249	Innate Immune System	TAS
R-HSA-168249	Innate Immune System	IEA
R-HSA-168256	Immune System	TAS
R-HSA-168256	Immune System	IEA
R-HSA-190828	Gap junction trafficking	TAS
R-HSA-190873	Gap junction degradation	TAS
R-HSA-194138	Signaling by VEGF	TAS
R-HSA-194315	Signaling by Rho GTPases	TAS
R-HSA-194315	Signaling by Rho GTPases	IEA
R-HSA-195258	RHO GTPase Effectors	TAS
R-HSA-195258	RHO GTPase Effectors	IEA
R-HSA-196025	Formation of annular gap junctions	TAS
R-HSA-199991	Membrane Trafficking	TAS
R-HSA-199991	Membrane Trafficking	IEA
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	TAS
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	IEA
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	TAS
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	IEA
R-HSA-212165	Epigenetic regulation of gene expression	TAS
R-HSA-2682334	EPH-Ephrin signaling	TAS
R-HSA-3214847	HATs acetylate histones	IEA
R-HSA-3247509	Chromatin modifying enzymes	IEA
R-HSA-373760	L1CAM interactions	TAS
R-HSA-373760	L1CAM interactions	IEA
R-HSA-389957	Prefoldin mediated transfer of substrate to CCT/TriC	IEA
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding	IEA
R-HSA-390450	Folding of actin by CCT/TriC	IEA
R-HSA-390466	Chaperonin-mediated protein folding	IEA
R-HSA-391251	Protein folding	IEA
R-HSA-392499	Metabolism of proteins	IEA
R-HSA-392499	Metabolism of proteins	TAS
R-HSA-3928662	EPHB-mediated forward signaling	TAS
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	TAS
R-HSA-418990	Adherens junctions interactions	IEA
R-HSA-418990	Adherens junctions interactions	TAS
R-HSA-421270	Cell-cell junction organization	IEA
R-HSA-421270	Cell-cell junction organization	TAS
R-HSA-422475	Axon guidance	TAS
R-HSA-422475	Axon guidance	IEA
R-HSA-437239	Recycling pathway of L1	TAS
R-HSA-437239	Recycling pathway of L1	IEA
R-HSA-4420097	VEGFA-VEGFR2 Pathway	TAS
R-HSA-445095	Interaction between L1 and Ankyrins	TAS
R-HSA-445095	Interaction between L1 and Ankyrins	IEA
R-HSA-446353	Cell-extracellular matrix interactions	TAS
R-HSA-446728	Cell junction organization	TAS
R-HSA-446728	Cell junction organization	IEA
R-HSA-4839726	Chromatin organization	IEA
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	TAS
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	TAS
R-HSA-5626467	RHO GTPases activate IQGAPs	TAS
R-HSA-5653656	Vesicle-mediated transport	TAS
R-HSA-5653656	Vesicle-mediated transport	IEA
R-HSA-5663202	Diseases of signal transduction	TAS
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	TAS
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	IEA
R-HSA-5663220	RHO GTPases Activate Formins	TAS
R-HSA-5663220	RHO GTPases Activate Formins	IEA
R-HSA-5673001	RAF/MAP kinase cascade	TAS
R-HSA-5674135	MAP2K and MAPK activation	TAS
R-HSA-5683057	MAPK family signaling cascades	TAS
R-HSA-5684996	MAPK1/MAPK3 signaling	TAS
R-HSA-5688426	Deubiquitination	TAS
R-HSA-5689603	UCH proteinases	TAS
R-HSA-5696394	DNA Damage Recognition in GG-NER	TAS
R-HSA-5696398	Nucleotide Excision Repair	TAS
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	TAS
R-HSA-597592	Post-translational protein modification	TAS
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	TAS
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	TAS
R-HSA-6802949	Signaling by RAS mutants	TAS
R-HSA-6802952	Signaling by BRAF and RAF fusions	TAS
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	TAS
R-HSA-6802957	Oncogenic MAPK signaling	TAS
R-HSA-73894	DNA Repair	TAS
R-HSA-74160	Gene expression (Transcription)	TAS
R-HSA-8856828	Clathrin-mediated endocytosis	TAS
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	TAS
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	IEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID	Title (Year)	Author	Journal
18671841	PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells. (2008 Jul 31)	Kriegova E	BMC Mol Biol
28981154	Variation in SWI/SNF Chromatin Remodeling Complex Proteins is Associated with Alcohol Dependence and Antisocial Behavior in Human Populations. (2017 Dec)	Mathies LD	Alcohol Clin Exp Res
28111298	Aerosol from Tobacco Heating System 2.2 has reduced impact on mouse heart gene expression compared with cigarette smoke. (2017 Mar)	Szostak J	Food Chem Toxicol